Tango Therapeutics Officer Reports Common Share Disposal Worth $157,660.5314
Principal Accounting Officer Jessica Newcomb reported a disposal of Tango Therapeutics common shares valued at $157,660.5314.
Principal Accounting Officer Jessica Newcomb reported a disposal of Tango Therapeutics common shares valued at $157,660.5314.